Metheptazine

Metheptazine
Clinical data
Other names	Metheptazine
ATC code	none;
Identifiers
	IUPAC name methyl 1,2-dimethyl-4-phenylazepane-4-carboxylate;
CAS Number	469-78-3 ;
PubChem CID	3047717;
ChemSpider	2310051 ;
UNII	93X4R66P5A;
ChEMBL	ChEMBL2104520 ;
Chemical and physical data
Formula	C16H23NO2
Molar mass	261.365 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES O=C(OC)C2(c1ccccc1)CC(N(C)CCC2)C;
	InChI InChI=1S/C16H23NO2/c1-13-12-16(15(18)19-3,10-7-11-17(13)2)14-8-5-4-6-9-14/h4-6,8-9,13H,7,10-12H2,1-3H3 ; Key:RAAFYFKWMRWOIT-UHFFFAOYSA-N ;
	(what is this?) (verify)

Metheptazine is an opioid analgesic from the phenazepane family. It was developed by American Home Products in the 1950s.^[1]

Metheptazine produces similar effects to other opioids, including analgesia, sedation, dizziness and nausea.

Metheptazine is not listed as a controlled substance under the Controlled Substances Act 1970 in the United States.^[2] The Canadian Controlled Drugs and Substances Act specifically excludes the phenazepine opioids from control.

References

↑ US 3316244, Bell SC, Childress SJ, "Process for the preparation of hexahydro-1,3-dimethyl-4-phenylazepine-4-carboxylic acid, ethyl ester", issued 25 April 1967, assigned to American Home Products Corporation.
↑ "Conversion Factors for Controlled Substances". U.S. Department of Justice, Drug Enforcement Administration, Diversion Control Division.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

[1] US 3316244, Bell SC, Childress SJ, "Process for the preparation of hexahydro-1,3-dimethyl-4-phenylazepine-4-carboxylic acid, ethyl ester", issued 25 April 1967, assigned to American Home Products Corporation.

[2] "Conversion Factors for Controlled Substances". U.S. Department of Justice, Drug Enforcement Administration, Diversion Control Division.

[1]

[2]